BEONE MEDICINES LTD. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BEONE MEDICINES LTD. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 30.07M shares, a 341.32% increase from fiscal 2024.
- BEONE MEDICINES LTD. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 6.81M shares, a 2.32% decline from fiscal 2023.
- BEONE MEDICINES LTD. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 6.97M shares, a 18.24% increase from fiscal 2022.
- BEONE MEDICINES LTD. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 5.90M shares, a 65.78% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 30.07M shares 10-K · filed 2026-02-26 | |
| 2024-12-31 | 6.81M shares 10-K · filed 2025-02-27 | |
| 2023-12-31 | 6.97M shares 10-K · filed 2025-02-27 | |
| 2022-12-31 | 5.90M shares 10-K · filed 2025-02-27 | |
| 2021-12-31 | 17.23M shares 10-K · filed 2024-02-26 | |
| 2020-12-31 | 29.71M shares 10-K · filed 2023-02-27 | |
| 2019-12-31 | 16.73M shares 10-K · filed 2022-02-28 |